Immune Biomarkers in the Prediction of Future Myocardial Infarctions in People With Human Immunodeficiency Virus.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
10 04 2020
Historique:
received: 11 06 2019
accepted: 12 08 2019
pubmed: 16 8 2019
medline: 7 1 2021
entrez: 16 8 2019
Statut: ppublish

Résumé

In a retrospective case control analysis, following adjustments for high-sensitivity C-reactive protein (hsCRP), traditional cardiovascular risk factors, and the CD4/CD8 T-cell ratio, higher lipopolysaccharide-binding protein (LBP) was associated with future myocardial infarctions in hsCRP human immunodeficiency virus (HIV). LBP may be a marker of cardiovascular risk with utility in HIV.

Identifiants

pubmed: 31414117
pii: 5550255
doi: 10.1093/cid/ciz765
pmc: PMC7346757
doi:

Substances chimiques

Biomarkers 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1764-1767

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI069424
Pays : United States
Organisme : NHLBI NIH HHS
ID : K08 HL128822
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI028697
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068634
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK118086
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI106701
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL139549
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI106716
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068636
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Nat Med. 2006 Dec;12(12):1365-71
pubmed: 17115046
Circulation. 2019 Jul 9;140(2):e98-e124
pubmed: 31154814
N Engl J Med. 1999 Jan 14;340(2):115-26
pubmed: 9887164
J Am Coll Cardiol. 2007 Jul 3;50(1):25-31
pubmed: 17601541
J Lipid Res. 2014 Jun;55(6):1120-30
pubmed: 24671012
J Infect Dis. 2010 Jun 15;201(12):1788-95
pubmed: 20446848
J Endocrinol. 2010 Mar;204(3):233-40
pubmed: 19837721
J Periodontal Res. 2014 Feb;49(1):1-9
pubmed: 23601005
Atherosclerosis. 2011 Nov;219(1):291-7
pubmed: 21722903
Biomark Med. 2011 Apr;5(2):171-86
pubmed: 21473720
Acta Dermatovenerol Alp Pannonica Adriat. 2014;23(3):43-7
pubmed: 25242159
AIDS. 2016 Sep 10;30(14):2195-203
pubmed: 27203715

Auteurs

Janine M Trevillyan (JM)

Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles.
Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Australia.

Carlee Moser (C)

Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

Judith S Currier (JS)

Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles.

Tamer Sallam (T)

Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH